Scolaris Content Display Scolaris Content Display

ترویج شست‌وشوی صورت برای پیشگیری از ابتلا به تراخم فعال

Contraer todo Desplegar todo

Referencias

Peach 1987 {published data only}

Peach H, Piper S, Devanesen D, Dixon B, Jefferies C, Braun P, et al. Northern Territory Trachoma Control and Eye Health Committee's Randomised Controlled Trial of the Effect of Eye Drops and Eye Washing on Follicular Trachoma Among Aboriginal Children. Report of the Northern Territory Trachoma Control and Eye Health Committee Incorporated1987:1‐33.

West 1995 {published data only}

West S, Lynch M. Protective effect of face‐washing against trachoma in Tanzania. Investigative Ophthalmology and Visual Science1993:ARVO E‐Abstract 2915.
West S, Muñoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BB, et al. Impact of face‐washing on trachoma in Kongwa, Tanzania. Lancet 1995;345(8943):155‐8.
West SK, Muñoz B, Lynch M, Kayongoya A, Mmbaga BB, Taylor HR. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. American Journal of Epidemiology 1996;143(1):73‐8.

Edwards 2006 {published data only}

Edwards T, Cumberland P, Hailu G, Todd J. Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia. Ophthalmology 2006;113(4):548‐55.

Khandekar 2005 {published data only}

Khandekar R, Mabry R, Al Hadrami K, Sarvanan N. Active trachoma, face washing (F) and environmental improvement (E) in a high‐risk population in Oman. Eastern Mediterranean Health Journal 2005;11(3):402‐9.

Khandekar 2006 {published data only}

Khandekar R, Ton TK, Do Thi P. Impact of face washing and environmental improvement on reduction of active trachoma in Vietnam‐a public health intervention study. Ophthalmic Epidemiology 2006;13(1):43‐52.

King 2011 {published data only}

King JD, Ngondi J, Kasten J, Diallo MO, Zhu M, Cromwell EA, et al. Randomised trial of face‐washing to develop a standard definition of a clean face for monitoring trachoma control programmes. Transactions of the Royal Society of Tropical Medicine and Hygiene 2011;105(1):7‐16.

Rubinstein 2006 {published data only}

Rubinstein RA, Lane SD, Sallam SA, Sheta AS, Gad ZM, Sherif AR, et al. Controlling blinding trachoma in the Egyptian Delta: Integrating clinical, epidemiological and anthropological understandings. Anthropology & Medicine 2006;13(2):99‐118.

Sutter 1983 {published data only}

Sutter E, Ballard R. Community participation in the control of trachoma in Gazankulu. Social Science and Medicine 1983;17(22):1813‐7.

NCT00348478 {unpublished data only}

NCT00348478. Impact of water and health education programs on trachoma and ocular C. trachomatis in Niger. clinicaltrials.gov/ct2/show/NCT00348478 (accessed 19 February 2014).

Bailey 2001

Bailey R, Lietman T. The SAFE strategy for the elimination of trachoma by 2020: will it work?. Bulletin of the World Health Organization 2001;79(3):233‐6.

Emerson 2000

Emerson PM, Cairncross S, Bailey RL, Mabey DCW. Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control. Tropical Medicine & International Health 2000;5(8):515‐27.

Evans 2011

Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD001860.pub3]

Glanville 2006

Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.

Higgins 2011

Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

ICEH 1999

International Centre for Eye Health. Slides/Text Teaching Series: No. 7 Trachoma. 2nd Edition. London: International Centre for Eye Health, 1999.

Pruss 2000

Pruss A, Mariotti SP. Preventing trachoma through environmental sanitation: a review of the evidence base. Bulletin of the World Health Organization 2000;78(2):258‐66.

Rabiu 2012

Rabiu M, Alhassan M, Ejere H, Evans JR. Environmental sanitary interventions for preventing active trachoma. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004003.pub4]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Stocks 2014

Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire C, Freeman MC. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta‐analysis. PLoS Medicine 2014;11(2):e1001605.

Thylefors 1987

Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization 1987;65(4):477‐83.

West 1991

West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. International Journal of Epidemiology 1991;20(4):1088‐92.

WHO 1997a

World Health Organization. Blindness and Visual Disability. Part II of VII: Major Causes Worldwide. Fact sheet N 143. 1997. www.who.int/inf‐fs/en/fact143.html (accessed 13 September 2001).

WHO 1997b

World Health Organization. Future approaches to trachoma control, report of a global scientific meeting; 1996 June 17‐20; Geneva. WHO//PBL/96.561997:1‐44.

WHO 2001

Négrel AD, Taylor HR, West S. Guidelines for the Rapid Assessment for Blinding Trachoma. WHO/PBD/GET/00.82001:1‐71.

WHO 2011

World Health Organization. Report of the Fifteenth Meeting of the WHO Alliance for the Global Elimination of Trachoma By 2020; 2011 April 18‐20; Geneva. http://trachoma.org/sites/default/files/guidesandmanuals/GET15REPORT4.pdf (accessed 7 July 2014):1‐46.

Ejere 2002

Ejere H, Alhassan M, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003659]

Ejere 2004

Ejere HOD, Alhassan MB, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003659.pub2]

Ejere 2012

Ejere HOD, Alhassan MB, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD003659.pub3]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Peach 1987

Methods

Study design: cluster‐RCT

Number randomized: 36 communities (1143 children)

Exclusions after randomization: none reported

Unit of analysis: individual children

Number analyzed: 1143 children total; 374 in eye drops group; 246 in eye washing group; 312 in combined group; 211 in non‐treatment group

Losses to follow‐up: 128 (11.2%) children total; 34 in eye drops group; 44 in eye washing group; 28 in combined group; 22 in non‐treatment group

How was missing data handled?: "Children which the trachoma workers could not follow‐up were assumed to have follicular trachoma and were included in the analysis."

Reported power calculation: sample size of 1500; power 80%

Unusual study design: "For each trachoma worker communities were allocated to all four groups and the allocation was done in stages…"

Participants

Country: Northern Territory of Australia

Age: 5 to 14 years; also included school children older than 14 years and pre‐school children (ages not specified)

Gender: boys and girls

Inclusion criteria for community: Aboriginal communities in the Northern Territory; population of about 100 or more

Inclusion criteria for children: Aboriginal children with follicular trachoma

Exclusion criteria for community: communities where “the yield of trachoma cases was expected to be small (≤6)"

Equivalence of baseline characteristics: no; "… more children aged 10 years old and above in the control group than in the other treatment groups …"

Interventions

Intervention 1: oily tetracycline eye drops daily for one week every month

Intervention 2: daily (every school day) eye washing

Intervention 3: oily tetracycline eye drops daily (every school day) for one week every month plus daily (every school day) eye washing

Intervention 4: no treatment

Length of follow‐up:

Planned: 3 months
Actual: mean days of follow‐up by intervention: 83.7 days for eye drops group, 85.6 days for eye washing group, 79.5 days for combined group, and 85.2 days for control group

Outcomes

Primary outcome, as defined in trial reports: follicular trachoma status (present or absent)
Secondary outcomes, as defined in trial reports: none
Adverse events: not reported

Intervals at which outcomes assessed: baseline and 3 months

Notes

Type of study: published

Funding sources: "The study was funded entirely by the Northern Territory Trachoma and Eye Health Committee Inc."

Disclosures of interest: not reported

Study period: not reported

Reported subgroup analyses: yes (trachoma worker, geographical zone); "None of the differences between the trachoma workers in the results they obtained for any of the treatment programmes was statistically significant"; "The reduction in the number of children with follicular trachoma after the combined programme was significantly greater in communities in zones 2 and 8 than in zone 1."

Trial investigators contacted?: yes; trial investigator contacted and provided information for previous versions of this review

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

A random number table was used to allocate communities to one of four treatment groups.

Allocation concealment (selection bias)

Unclear risk

Allocation concealment not reported.

Masking outcome assessors

Low risk

"Trachoma workers did not know what treatment programme, if any, had been allocated to a particular community."

"For each trachoma worker communities were allocated to all four groups and the allocation was done in stages to control for observer variation and a possible learning effect by the trachoma workers".

Incomplete outcome data (attrition bias)
All outcomes

Low risk

128 (11.2%) children total (34 in eye drops group, 44 in eye washing group, 28 in combined group, 22 in non‐treatment group) lost to follow‐up; "The children whom the trachoma workers were unable to follow‐up were assumed to have follicular trachoma and were included in the analysis… The data were re‐analyzed after having excluded the missing cases and the overall results were similar"; "Level of missingness differed by treatment group – eye washing group had the highest % of missing cases".

Selective reporting (reporting bias)

Unclear risk

No protocol available.

Other bias

Unclear risk

This was a cluster‐RCT; however, data were analyzed at the individual participant level without accounting for the cluster design; sensitivity and specificity of aboriginal trachoma workers in diagnosing follicular trachoma varied.

West 1995

Methods

Study design: cluster‐RCT

Number randomized: 6 villages (1417 children); villages paired so that one village was assigned to the intervention and the other assigned to control;

Pair 1: 178 children in intervention village and 231 in control village;

Pair 2: 248 children in intervention village and 247 in control village;

Pair 3: 254 children in intervention village and 259 in control village;

Total: 680 children in intervention group and 737 in control group

Exclusions after randomization: none reported

Unit of analysis: villages (overall and by pairs)

Number analyzed: 6 villages

Losses to follow‐up: 113 children (8% of 1417); "reasons for loss to follow‐up were that the child died (2%) or that the family moved out of the village or out of the study area (6%)"

How was missing data handled?: not reported

Reported power calculation: none

Unusual study design?: pairs of villages matched for baseline characteristics; "We randomized three pairs of villages‐one of each pair would receive mass treatment followed by the health education campaign, and the other would receive mass treatment alone. The pairs of villages were matched for maternal education (years of formal education), baseline prevalence of clean faces in young children, and trachoma status (based on clinical observation at enrolment). Within each village, a complete census was taken by trained field‐workers. 250 eligible households containing at least 1 child aged 1‐7 years were randomly selected in each village. Within the household, 1 child was randomly selected to take part in the study."

Participants

Country: Kongwa, Tanzania

Age: 1 to 7 years

Gender: boys and girls

Inclusion criteria: 1) children aged 1 to 7 years in the area where trachoma was endemic; 2) face washing campaign could be carried out at village level; 3) households containing at least 1 child

Exclusion criteria: none reported

Equivalence of baseline characteristics: no; pairs of villages were matched for maternal education, and baseline prevalence of clean faces in young children, and trachoma status based on clinical observation at enrolment; however, the prevalence of trachoma may have been higher in the intervention villages based on photographic evidence of trachoma

Interventions

Intervention 1: 30‐day mass treatment campaign with topical tetracycline ointment once daily followed by intensive 1‐month community‐based participatory hygiene intervention, including neighborhood meetings and several reinforcement activities to improve face washing of the young children, during and after mass treatment

Intervention 2: 30‐day mass treatment campaign with topical tetracycline ointment once daily alone

Length of follow‐up:

Planned: 12 months

Actual: 12 months

Outcomes

Outcomes, as defined in trial reports: facial cleanliness based on the presence or absence of nasal discharge, ocular discharge, and flies on the face; trachoma status evaluated by photographs of the right eye of each index child graded on the WHO simplified grading scheme

Adverse events: not reported

Intervals at which outcomes assessed: baseline, month 2 (1 month after the end of the mass treatment campaign), 6 and 12 months

Notes

Type of study: published

Funding sources: "This work was supported by the Edna McDonnell Clark Foundation and the Central Eye Health Foundation."

Disclosures of interest: one author (Dr. Sheila West) is a Research to Prevent Blindness senior scientific investigator

Study period: not reported

Reported subgroup analyses: yes (trachoma status at baseline and prevalence of clean faces at baseline, 2 months, 6 months and 12 months)

Trial investigators contacted?: yes; trial investigator contacted and provided information for previous versions of this review

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Method of randomization not reported.

Allocation concealment (selection bias)

Unclear risk

Allocation concealment not reported.

Masking outcome assessors

Low risk

"Records of facial cleanliness were made by trained observers who were not part of the hygiene intervention team." "At each time, the tarsal plate of the right eye of each index child was photographed. The photographs were graded on the WHO simplified grading scheme by one examiner who was unaware of the randomization status of the village and the time of the photograph."

Incomplete outcome data (attrition bias)
All outcomes

Low risk

"92% were followed up for 1 year. The main reasons for loss to follow‐up were that the child died (2%) or that the family moved out of the village or out of the study area (6%)."

Selective reporting (reporting bias)

Unclear risk

No protocol available.

Other bias

Low risk

No other sources of bias identified.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Edwards 2006

Face washing was not part of the study intervention. Communities were randomly assessed to different health education programs:

  1. Radio messaging in 10 kebele not in the non‐governmental organization (NGO) activity areas;

  2. Radio messaging in 10 kebele within the NGO activity areas;

  3. Radio messaging and information, education and communication (IEC) materials in 10 kebele within the NGO activity areas;

  4. Radio messaging, IEC materials, and video van activities in 10 kebele within the NGO activity areas.

Khandekar 2005

Participants were not randomized to a face‐washing program. Houses were randomly selected in communities where the face‐washing "F" and education "E" components of the trachoma initiative were implemented.

Khandekar 2006

Unable to separate the effect of face washing from environmental sanitation interventions as both were indirectly examined as "one intervention".

King 2011

Study aim was to develop standardized definition for a clean face in trachoma prevention.

Rubinstein 2006

Study intervention is health education promotion of face washing; face washing was not part of the study intervention. The educational program had a primary and five secondary messages. The primary message is: "Eye disease can be prevented by washing children's faces with soap and water at least once each day." The secondary messages are:

  1. Washing children’s faces with soap and water removes germs which can infect the eyes.

  2. Eye disease can be reduced by always using latrines or burying human feces.

  3. Eye disease can be reduced by burning or burying refuse such as food scraps and peelings from fruits and vegetables.

  4. A dirty towel can carry infection from one child’s eyes to the eyes of another child.

  5. Anything that touches eyes, including hands, can spread eye infections.

Sutter 1983

Not a RCT; communities were not randomly assigned care groups. Care groups are villages who are involved in prevention and treatment of trachoma.

Characteristics of studies awaiting assessment [ordered by study ID]

NCT00348478

Methods

Study design: cluster‐RCT

Unit of randomization: villages. "We will randomly select six villages to be the "intervention" villages and six villages to be the "control" villages. We will aim to include 360 children, randomly selected from the 6 "intervention" villages (one per mother for a total of up to 60 in each village) and 360 children randomly selected from 6 "control" villages."

Participants

Country: Niger

Age: 6 months to 5 years and five months

Gender: boys and girls

Inclusion criteria: villages of size between 900 to 2100 residents as of 1995 census in Kornaka West district of Niger; village leadership approval of entry of village in the study; sentinel children ages 6 months to 5 years and five months

Exclusion criteria: village already has health education program for hygiene; village within 5 km of a well; child already has a sibling in the study population

Interventions

Intervention 1: water and health education program to improve hygiene; "World Vision plans water wells to serve a population of about 300, in villages of about 300‐5,000 persons. Thus each village has around 1‐17 wells. The goal is to provide water within 500 meters with a wait time of less than 15 minutes. Health education on use of water and hygiene practices is also part of services delivery. A World Vision Area Development Program officer establishes and trains a water and sanitation committee to provide health education for their village."

Intervention 2: "control" villages where services not available immediately; "villages where the planning process has just started and wells would not be drilled for over two years"

Length of follow‐up:

Planned: 3 years

Outcomes

Primary outcome, as defined in trial: trachoma (ocular C. trachomatis infection)
Secondary outcome, as defined in trial: under five years
Adverse events: not specified

Intervals at which outcomes assessed: baseline, 1, 2, and 3 years from baseline

Notes

Type of study: unpublished

Funding sources: Johns Hopkins University, World Vision, CONRAD

Disclosures of interest: not reported

Study period: not reported

Planned subgroup analyses: none reported

Data and analyses

Open in table viewer
Comparison 1. Eye wash versus control

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Presence of follicular trachoma Show forest plot

1

1143

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.96, 1.11]

Analysis 1.1

Comparison 1 Eye wash versus control, Outcome 1 Presence of follicular trachoma.

Comparison 1 Eye wash versus control, Outcome 1 Presence of follicular trachoma.

1.1 with tetracycline eye drops in both groups

1

686

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.93, 1.14]

1.2 without tetracycline eye drops in both groups

1

457

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.93, 1.13]

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Eye wash versus control, Outcome 1 Presence of follicular trachoma.
Figuras y tablas -
Analysis 1.1

Comparison 1 Eye wash versus control, Outcome 1 Presence of follicular trachoma.

Comparison 1. Eye wash versus control

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Presence of follicular trachoma Show forest plot

1

1143

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.96, 1.11]

1.1 with tetracycline eye drops in both groups

1

686

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.93, 1.14]

1.2 without tetracycline eye drops in both groups

1

457

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.93, 1.13]

Figuras y tablas -
Comparison 1. Eye wash versus control